第一项始终是图钉的来源。总体可信度是各份资料对上方所用开始和结束时间支持程度的加权平均；资料每比最新的一份旧 180 天，权重减半。
J&J set the date itself: CFO Joseph Wolk said on the 15 July Q2 call "We look forward to sharing more on strategy, growth catalysts and a longer-term outlook at our Enterprise business review on December 8", and the source reports he "expects to present stronger growth expectations at its Dec. 8 investor day"; no time or venue has been announced, so the pin sits at J&J's headquarters as an all-day date.
J&J's posted transcript of Wolk's fireside chat: "another Investor Day coming up in December 8. You're going to see growth rates that are better than that", with more on cash flow and the oncology outlook promised for that day.[1]
CEO Joaquin Duato previews the "enterprise business review here in early December" - held "every three years" - and its two topics; gives early December rather than the day.[1]
MedTech chief Tim Schmid: "December 8th of this year will be our next Investor Day", adding that details on when OTTAVA becomes a material contributor come "at the EBR on December 8".[1]
The first time J&J named the date, in the CFO's prepared remarks: "a longer-term outlook at our Enterprise business review on December 8".[1]
有遗漏或错误吗？用你自己的话说明：能佐证此图钉的链接、不同的开始或结束日期及理由，或缺失、有误的信息。AI 会对照此图钉的来源进行核实，搜索更好的来源，并添加任何支持你说法的页面。图钉自身的来源仍然最重要。
